Нодрига

Нодрига (Dasatinib) is an oral prescription medication used to treat certain types of leukemia. It belongs to a class of drugs known as kinase inhibitors. This product is manufactured by Alkaloid-Int D.O.O. and is available in the EU market.

Нодрига (Dasatinib) is primarily used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) in adults. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps to slow or stop the spread of cancer cells in the body.

Users of Нодрига (Dasatinib) may experience effects such as nausea, headache, or fatigue. Some individuals report changes in appetite or mild digestive discomfort. These effects are generally temporary and vary by individual.

Нодрига should be handled with care and stored as directed. Keep it out of reach of children and pets. If you are pregnant, planning pregnancy, or breastfeeding, consult a healthcare provider before use. Always follow your doctor’s instructions for safe handling.

Нодрига may interact with other medications, including certain antibiotics, antifungals, and blood thinners. Avoid grapefruit products while taking this medication, as they can affect how it works. Always inform your healthcare provider about all medications and supplements you are using.